Senior insider sale
Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$272.2K
9K shares
What this filing means
MILANOVA TSVETA plans to sell 9K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $272.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001439222-26-000052
Officer· Chief Commercial Officer
Since Mar 2026
9K
Shares to sell
$272.2K
Approx. market value
3.26K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
4/2/2026
3.26KTotal acquired3.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/2/2026 | Vesting of Restricted Stock Units Not Applicable | 3.26K | — |
| Total | 3.26K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.87K
Market value
$83.1K
3/2/2026
—Completed
Units to sell
2.87K
Market value
$77.6K
1/5/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
3.26K
Market value
$111.5K
4/2/2026
Total
Units
9K
Value
$272.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 2.87K | $83.1K | — | Completed |
1/5/2026 | 2.87K | $77.6K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 3.26K | $111.5K | Nasdaq | Planned |
| Total | 9K | $272.2K | ||